Trial intelligence / Profile preview

Repurposing disulfiram as treatment for metastatic colorectal cancer

2019-002748-25Phase 2Completed

Sponsor
University Hospital Odense
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of disulfiram in colorectal cancer (CRC) and metastatic colorectal adenocarcinoma (mCRC), sponsored by University Hospital Odense. Started Jul 2019; status: completed.

02

Drugs

disulfiram
03

Conditions

colorectal cancer (CRC)metastatic colorectal adenocarcinoma (mCRC)

Beyond the preview

Go deeper on 2019-002748-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-002748-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call